MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours

The development of childhood solid tumours is tied to early developmental processes. These tumours may be complex and heterogeneous, and elucidating the aberrant mechanisms that alter the early embryonic environment and lead to disease is essential to our understanding of how these tumours function. MicroRNAs (miRNAs) are vital regulators of gene expression at all stages of development, and their crosstalk via developmental signalling pathways is essential for orchestrating regulatory control in processes such as proliferation, differentiation and apoptosis of cells. Oncogenesis, from aberrant miRNA expression, can occur through amplification and overexpression of oncogenic miRNAs (oncomiRs), genetic loss of tumour suppressor miRNAs, and global miRNA reduction from genetic and epigenetic alterations in the components regulating miRNA biogenesis. While few driver mutations have been identified in many of these types of tumours, abnormal miRNA expression has been found in a number of childhood solid tumours compared to normal tissue. An exploration of the network of key developmental pathways and interacting miRNAs may provide insight into the development of childhood solid malignancies and how key regulators are affected. Here we present a comprehensive introduction to the roles and implications of miRNAs in normal early development and childhood solid tumours, highlighting several tumours in depth, including embryonal brain tumours, neuroblastoma, osteosarcoma, Wilms tumour, and hepatoblastoma. In light of recent literature describing newer classifications and subtyping of tumours based on miRNA profiling, we discuss commonly identified miRNAs, clusters or families associated with several solid tumours and future directions for improving therapeutic approaches.

[1]  Zhenfeng Duan,et al.  MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.

[2]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[3]  R. Stallings,et al.  MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. , 2011, Cancer letters.

[4]  L. Strong,et al.  Hepatoblastoma and familial adenomatous polyposis. , 1988, Journal of the National Cancer Institute.

[5]  T. Ludwig,et al.  Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.

[6]  M. Garami,et al.  microRNA expression might predict prognosis of epithelial hepatoblastoma , 2014, Virchows Archiv.

[7]  J Khan,et al.  The MYCN oncogene is a direct target of miR-34a , 2008, Oncogene.

[8]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[9]  Yufei Huang,et al.  De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development , 2013, PloS one.

[10]  E. Hiyama Pediatric hepatoblastoma: diagnosis and treatment. , 2014, Translational pediatrics.

[11]  Ji Wu,et al.  Signaling pathways and preimplantation development of mammalian embryos , 2007, The FEBS journal.

[12]  T. McLean,et al.  Pediatric genitourinary tumors , 2007, Current opinion in oncology.

[13]  Alexander van Oudenaarden,et al.  Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures. , 2010, Molecular cell.

[14]  S. Elledge,et al.  Dicer is essential for mouse development , 2003, Nature Genetics.

[15]  W. Cho MicroRNAs as therapeutic targets and their potential applications in cancer therapy , 2012, Expert opinion on therapeutic targets.

[16]  P. Grundy,et al.  Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour , 2014, Nature Communications.

[17]  W. Xiong,et al.  Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. , 2011, Omics : a journal of integrative biology.

[18]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[19]  T. Gregory,et al.  Coincidence, coevolution, or causation? DNA content, cellsize, and the C‐value enigma , 2001, Biological reviews of the Cambridge Philosophical Society.

[20]  G. Mirone,et al.  The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review). , 2016, Oncology reports.

[21]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[22]  B. Kushner,et al.  Familial neuroblastoma. Case reports, literature review, and etiologic considerations , 1986, Cancer.

[23]  W. Cho,et al.  The emerging role of miRNAs in combined cancer therapy , 2015, Expert opinion on biological therapy.

[24]  S. Hammond,et al.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.

[25]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[26]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[27]  V. Kim,et al.  MicroRNA maturation: stepwise processing and subcellular localization , 2002, The EMBO journal.

[28]  Kevin B. Jones,et al.  miRNA signatures associate with pathogenesis and progression of osteosarcoma. , 2012, Cancer research.

[29]  U. Kutay,et al.  Nuclear Export of MicroRNA Precursors , 2004, Science.

[30]  Julia B. Cordero,et al.  MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer , 2014, Cancer cell.

[31]  C. Thiele,et al.  Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets , 2012, Clinical Cancer Research.

[32]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[33]  Zhang Liping,et al.  Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury , 2013, PloS one.

[34]  M. Steenman,et al.  Genetics of Beckwith‐Wiedemann syndrome‐associated tumors: Common genetic pathways , 2000, Genes, chromosomes & cancer.

[35]  W. Weiss,et al.  Childhood tumors of the nervous system as disorders of normal development , 2006, Current opinion in pediatrics.

[36]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[37]  G. Perilongo,et al.  Childhood solid tumours: a developmental disorder , 2005, Nature Reviews Cancer.

[38]  Anton J. Enright,et al.  Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. , 2010, Cancer research.

[39]  M. Verma,et al.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics , 2016, Cancer medicine.

[40]  L. Lim,et al.  An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.

[41]  Wei Wang,et al.  MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.

[42]  A. Abarrategi,et al.  Bone Environment is Essential for Osteosarcoma Development from Transformed Mesenchymal Stem Cells , 2014, Stem cells.

[43]  Sara M. Federico,et al.  The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. , 2016, Developmental biology.

[44]  Anton J. Enright,et al.  Solid Tumors of Childhood Display Specific Serum microRNA Profiles , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[45]  R. Stallings,et al.  MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. , 2009, Current pharmaceutical design.

[46]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[47]  Nada Jabado,et al.  Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR , 2013, Nature Genetics.

[48]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[49]  B. Cowan,et al.  Pediatric genitourinary tumors. , 1992, Current opinion in oncology.

[50]  M. Rivera,et al.  Wilms' tumour: connecting tumorigenesis and organ development in the kidney , 2005, Nature Reviews Cancer.

[51]  Hsien-Da Huang,et al.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..

[52]  P. Liberski,et al.  Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma , 2016, PloS one.

[53]  M. Esteller,et al.  Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.

[54]  Fedor V. Karginov,et al.  The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma , 2009, Proceedings of the National Academy of Sciences.

[55]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[56]  S. Navarro,et al.  Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion , 2013, PloS one.

[57]  Wanbo Liu,et al.  Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study , 2016, Pediatric Surgery International.

[58]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[59]  M. Cohen,et al.  Beckwith-Wiedemann Syndrome: Historical, Clinicopathological, and Etiopathogenetic Perspectives , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[60]  Michaela Scherr,et al.  Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. , 2007, Blood.

[61]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  F. Cetani,et al.  The microRNA cluster C19MC is deregulated in parathyroid tumours. , 2012, Journal of molecular endocrinology.

[63]  Ximing J. Yang,et al.  The E2F3-Oncomir-1 axis is activated in Wilms' tumor. , 2008, Cancer research.

[64]  V. P. Collins,et al.  Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. , 2009, Cancer cell.

[65]  A. McMahon,et al.  Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. , 2008, Cell stem cell.

[66]  S. Kawasaki,et al.  Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. , 1998, Cancer research.

[67]  M. Soares,et al.  Identification of Differentially Expressed MicroRNAs in Osteosarcoma , 2011, Sarcoma.

[68]  S. Ohno,et al.  So much "junk" DNA in our genome. , 1972, Brookhaven symposia in biology.

[69]  M. Esteller,et al.  DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer , 2011, Oncogene.

[70]  Jun Li,et al.  miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. , 2010, Biochemical and biophysical research communications.

[71]  W. Foulkes,et al.  Biallelic DICER1 mutations occur in Wilms tumours , 2013, The Journal of pathology.

[72]  W. Cho,et al.  MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer. , 2016, Current cancer drug targets.

[73]  U. Lehmann,et al.  Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.

[74]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[75]  Hiromu Suzuki,et al.  DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.

[76]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[77]  R. Stallings,et al.  MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 , 2013, Molecular Cancer.

[78]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[79]  Aniruddha Chatterjee,et al.  A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients , 2015, Scientific Reports.

[80]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[81]  P. Pagel,et al.  MicroRNA‐492 is processed from the keratin 19 gene and up‐regulated in metastatic hepatoblastoma , 2011, Hepatology.

[82]  D. Kaufman,et al.  Cell cycle control, DNA repair and initiation of carcinogenesis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  J. Vandesompele,et al.  Identification of miRNAs contributing to neuroblastoma chemoresistance , 2015, Computational and structural biotechnology journal.

[84]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[85]  Anton J. Enright,et al.  Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma , 2014, Oncogenesis.

[86]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[87]  P. Zamore,et al.  ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.

[88]  Henning Urlaub,et al.  Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.

[89]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[90]  Caterina Giannini,et al.  MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. , 2013, Neuro-oncology.

[91]  H. Horvitz,et al.  MicroRNA Expression in Zebrafish Embryonic Development , 2005, Science.

[92]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[93]  Michael H Handler,et al.  Survey of MicroRNA expression in pediatric brain tumors , 2011, Pediatric blood & cancer.

[94]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[95]  Gerald Hoefler,et al.  miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. , 2012, Carcinogenesis.

[96]  Yi Tie,et al.  Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest , 2008, FEBS letters.

[97]  C. Croce,et al.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.

[98]  Frank J. Slack,et al.  Aberrant Regulation and Function of MicroRNAs in Cancer , 2014, Current Biology.

[99]  B. Cullen,et al.  Sequence requirements for micro RNA processing and function in human cells. , 2003, RNA.

[100]  R. Stallings,et al.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. , 2007, Cancer research.

[101]  A. Donfrancesco,et al.  Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.

[102]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[103]  Kathy Pritchard-Jones,et al.  The yin and yang of kidney development and Wilms’ tumors , 2015, Genes & development.

[104]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[105]  Dinesh Rakheja,et al.  Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours , 2014, Nature Communications.

[106]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[107]  F. Zindy,et al.  Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. , 2013, Cancer Research.

[108]  D. Merico,et al.  Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network , 2016, Oncotarget.

[109]  Sharon J. Diskin,et al.  A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene , 2008, Molecular Cancer Research.

[110]  M. Eccles,et al.  Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples , 2015, GigaScience.

[111]  Yan Zeng,et al.  Biogenesis of Mammalian MicroRNAs: A Global View , 2012, Genom. Proteom. Bioinform..

[112]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[113]  Vincent De Guire,et al.  An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.

[114]  T. Yatskievych,et al.  MicroRNA expression during chick embryo development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[115]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[116]  E. Bertrand,et al.  Human let-7 stem-loop precursors harbor features of RNase III cleavage products. , 2003, Nucleic acids research.

[117]  M. Shago,et al.  CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity , 2014, Acta Neuropathologica.

[118]  V. Tarasov,et al.  Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.

[119]  Kai Li,et al.  MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. , 2010, Biochemical and biophysical research communications.

[120]  E. Furth,et al.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.

[121]  David Z. Chen,et al.  Architecture of the human regulatory network derived from ENCODE data , 2012, Nature.

[122]  R. Stallings,et al.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells , 2007, Oncogene.

[123]  M. Eccles,et al.  DNA methylation and epigenomics: new technologies and emerging concepts , 2015, Genome Biology.

[124]  M. O'sullivan,et al.  What Do We Know about the Role of miRNAs in Pediatric Sarcoma? , 2015, International journal of molecular sciences.

[125]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[126]  Yu Wei,et al.  Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. , 2008, Cancer cell.

[127]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[128]  Chih-Hao Chang,et al.  microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. , 2010, Cancer research.

[129]  Hao Zhu,et al.  Lin28 sustains early renal progenitors and induces Wilms tumor , 2014, Genes & development.

[130]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[131]  Michael D. Taylor,et al.  MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma* , 2012, The Journal of Biological Chemistry.